|
J Biol Chem, Vol. 274, Issue 21, 15110-15114, May 21, 1999
Cholesterol-dependent Generation of a Seeding
Amyloid -Protein in Cell Culture
Tetsuya
Mizuno ,
Makoto
Nakata§,
Hironobu
Naiki¶,
Makoto
Michikawa ,
Rong
Wang ,
Christian
Haass**, and
Katsuhiko
Yanagisawa
From the Department of Dementia Research, National
Institute for Longevity Sciences, Gengo 36-3, Morioka, Obu, 474-8522, Japan, § Protein Research Foundation, Peptide Institute,
Inc., 4-1-2 Ina, Minoh, Osaka 562, Japan, ¶ Department of
Pathology, Fukui Medical University, Fukui 910-1193, Japan,
Laboratory for Mass Spectrometry, Rockefeller University, New
York, New York 10021-6399, and ** Department of Molecular Biology, J5,
Central Institute for Mental Health, 68159 Mannheim, Germany
Deposition of aggregated amyloid -protein
(A ), a proteolytic cleavage product of the amyloid precursor protein
(1), is a critical step in the development of Alzheimer's disease (2). However, we are far from understanding the molecular mechanisms underlying the initiation of A polymerization in vivo.
Here, we report that a seeding A , which catalyzes the
fibrillogenesis of soluble A , is generated from the apically
missorted amyloid precursor protein in cultured epithelial cells.
Furthermore, the generation of this A depends exclusively on the
presence of cholesterol in the cells. Taken together with mass
spectrometric analysis of this novel A and our recent study (3), it
is suggested that a conformationally altered form of A , which acts
as a "seed" for amyloid fibril formation, is generated in
intracellular cholesterol-rich microdomains.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Ariga, M. P. McDonald, and R. K. Yu
Thematic Review Series: Sphingolipids. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review
J. Lipid Res.,
June 1, 2008;
49(6):
1157 - 1175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Bi, M. Baudry, J. Liu, Y. Yao, L. Fu, F. Brucher, and G. Lynch
Inhibition of Geranylgeranylation Mediates the Effects of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Inhibitors on Microglia
J. Biol. Chem.,
November 12, 2004;
279(46):
48238 - 48245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. B. Chauhan
Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease
J. Lipid Res.,
November 1, 2003;
44(11):
2019 - 2029.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Ehehalt, P. Keller, C. Haass, C. Thiele, and K. Simons
Amyloidogenic processing of the Alzheimer {beta}-amyloid precursor protein depends on lipid rafts
J. Cell Biol.,
January 2, 2003;
160(1):
113 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jaworska-Wilczynska, G. M. Wilczynski, W. K. Engel, D. K. Strickland, K. H. Weisgraber, and V. Askanas
Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle
Neurology,
February 12, 2002;
58(3):
438 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S.-S. Wang, D. L. Rymer, and T. A. Good
Reduction in Cholesterol and Sialic Acid Content Protects Cells from the Toxic Effects of beta -Amyloid Peptides
J. Biol. Chem.,
November 2, 2001;
276(45):
42027 - 42034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lesuisse, G. Xu, J. Anderson, M. Wong, J. Jankowsky, G. Holtz, V. Gonzalez, P. C. Y. Wong, D. L. Price, F. Tang, et al.
Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice
Hum. Mol. Genet.,
October 1, 2001;
10(22):
2525 - 2537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Simons, P. Keller, J. Dichgans, and J. B. Schulz
Cholesterol and Alzheimer's disease: Is there a link?
Neurology,
September 25, 2001;
57(6):
1089 - 1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Chochina, N. A. Avdulov, U. Igbavboa, J. P. Cleary, E. O. O'Hare, and W. G. Wood
Amyloid {beta}-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region
J. Lipid Res.,
August 1, 2001;
42(8):
1292 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hamanaka, Y. Katoh-Fukui, K. Suzuki, M. Kobayashi, R. Suzuki, Y. Motegi, Y. Nakahara, A. Takeshita, M. Kawai, K. Ishiguro, et al.
Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice
Hum. Mol. Genet.,
February 12, 2000;
9(3):
353 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sawamura, M. Morishima-Kawashima, H. Waki, K. Kobayashi, T. Kuramochi, M. P. Frosch, K. Ding, M. Ito, T.-W. Kim, R. E. Tanzi, et al.
Mutant Presenilin 2 Transgenic Mice. A LARGE INCREASE IN THE LEVELS OF Abeta 42 IS PRESUMABLY ASSOCIATED WITH THE LOW DENSITY MEMBRANE DOMAIN THAT CONTAINS DECREASED LEVELS OF GLYCEROPHOSPHOLIPIDS AND SPHINGOMYELIN
J. Biol. Chem.,
September 1, 2000;
275(36):
27901 - 27908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kakio, S.-i. Nishimoto, K. Yanagisawa, Y. Kozutsumi, and K. Matsuzaki
Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid beta -Protein, an Endogenous Seed for Alzheimer Amyloid
J. Biol. Chem.,
June 29, 2001;
276(27):
24985 - 24990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gu, H. Fujioka, R. S. Mishra, R. Li, and N. Singh
Prion Peptide 106-126 Modulates the Aggregation of Cellular Prion Protein and Induces the Synthesis of Potentially Neurotoxic Transmembrane PrP
J. Biol. Chem.,
January 11, 2002;
277(3):
2275 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|